Literature DB >> 11931852

Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-Delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids.

Omar Quraishi1, Joseph A Mancini, Denis Riendeau.   

Abstract

Prostaglandin E(2) synthase (PGE synthase) is one of the membrane-associated proteins in the eicosanoid and glutathione metabolism (MAPEG) family of microsomal enzymes and constitutes a novel inducible enzyme involved in inflammation and pyretic responses. We report, using a reversed-phase HPLC assay for the production of tritiated prostaglandin E(2) (PGE(2)) by membranes from cells overexpressing human microsomal PGE synthase, that PGE synthase activity is inhibited effectively by 15-deoxy-Delta(12,14)-prostaglandin J(2) and arachidonic acid. The anti-inflammatory compound 15-deoxy-PGJ(2) was considerably more potent at inhibiting PGE synthase (IC(50)=0.3 microM) than the closely related PGJ(2) or Delta(12)-PGJ(2), or the reaction product PGE(2). Arachidonic acid, docosahexaenoic acid, and eicosapentaenoic acid inhibited PGE synthase with a similar potency (IC(50)=0.3 microM) and were more potent inhibitors than various fatty acid analogues. The present results on the inducible PGE synthase extend observations on the ability to bind arachidonic acid to another member of the MAPEG family, and also suggest a novel mechanism of action for the anti-inflammatory effects of DHA, EPA, and 15-deoxy-PGJ(2).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11931852     DOI: 10.1016/s0006-2952(02)00844-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases.

Authors:  Qian Wang; Yuanyuan Li; Mengying Wu; Songming Huang; Aihua Zhang; Yue Zhang; Zhanjun Jia
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.

Authors:  Zhonghua Xia; Aixia Yan
Journal:  Mol Divers       Date:  2017-05-08       Impact factor: 2.943

3.  Novel human mPGES-1 inhibitors identified through structure-based virtual screening.

Authors:  Adel Hamza; Xinyun Zhao; Min Tong; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Bioorg Med Chem       Date:  2011-08-25       Impact factor: 3.641

4.  Microsomal Prostaglandin E Synthase-1 Expression by Aortic Smooth Muscle Cells Attenuates the Differentiated Phenotype.

Authors:  Oreoluwa O Adedoyin; Charles D Loftin
Journal:  J Cardiovasc Pharmacol       Date:  2016-08       Impact factor: 3.105

Review 5.  mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators".

Authors:  Masako Nakanishi; Vijay Gokhale; Emmanuelle J Meuillet; Daniel W Rosenberg
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

Review 6.  Identification and development of mPGES-1 inhibitors: where we are at?

Authors:  Hui-Hua Chang; Emmanuelle J Meuillet
Journal:  Future Med Chem       Date:  2011-11       Impact factor: 3.808

7.  Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.

Authors:  A Koeberle; F Pollastro; H Northoff; O Werz
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

8.  Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E₂ synthase-1 (mPGES-1).

Authors:  Birgit Waltenberger; Katja Wiechmann; Julia Bauer; Patrick Markt; Stefan M Noha; Gerhard Wolber; Judith M Rollinger; Oliver Werz; Daniela Schuster; Hermann Stuppner
Journal:  J Med Chem       Date:  2011-04-20       Impact factor: 7.446

Review 9.  Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.

Authors:  Jessica K Norberg; Earlphia Sells; Hui-Hua Chang; Srinivas R Alla; Shuxing Zhang; Emmanuelle J Meuillet
Journal:  Pharm Pat Anal       Date:  2013-03

10.  Inhibition of cyclooxygenases 1 and 2 by the phospholipase-blocker, arachidonyl trifluoromethyl ketone.

Authors:  H J Leis; W Windischhofer
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.